Dupont Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-13,228	Closed	-$211K	–	749
2022 Q4	$211K	Sell	13,228 -27,166	-67%	-$425K	0.01%	777
2022 Q3	$661K	Buy	40,394 +20,011	+98%	+$324K	0.04%	541
2022 Q2	$287K	Hold	20,383	–	–	0.01%	871
2022 Q1	$494K	Sell	20,383 -1,803	-8%	-$43.6K	0.02%	752
2021 Q4	$518K	Buy	22,186 +6,671	+43%	+$134K	0.02%	760
2021 Q3	$258K	Buy	+15,515	New	+$299K	0.01%	1124
2021 Q2	–	Sell	-3,188	Closed	-$82K	–	1717
2021 Q1	$82K	Sell	3,188 -7,181	-69%	-$316K	﹤0.01%	1379
2020 Q4	$554K	Buy	10,369 +2,853	+38%	+$142K	0.01%	802
2020 Q3	$310K	Buy	7,516 +4,454	+145%	+$192K	0.01%	958
2020 Q2	$148K	Sell	3,062 -16,040	-84%	-$770K	﹤0.01%	1196
2020 Q1	$807K	Sell	19,102 -2,404	-11%	-$99.1K	0.02%	515
2019 Q4	$920K	Buy	21,506 +3,685	+21%	+$160K	0.02%	600
2019 Q3	$641K	Sell	17,821 -1,911	-10%	-$57.9K	0.01%	674
2019 Q2	$527K	Buy	+19,732	New	+$504K	0.01%	757